clothiapine has been researched along with loxapine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartoszyk, GD; Böttcher, H; Liao, Y; Meier, E; Rodenhuis, N; Seyfried, CA; Sundell, S; Timmerman, W; Venhuis, BJ; Wikström, H | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
de Esch, IJ; Fratantoni, SA; Hulscher, S; Hulshof, JW; Leurs, R; Smit, MJ; Verheij, MH; Victorina, J; Vischer, HF | 1 |
Dilly, S; Liégeois, JF | 1 |
4 other study(ies) available for clothiapine and loxapine
Article | Year |
---|---|
New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
Topics: Animals; Antipsychotic Agents; Benzazepines; Brain; Catalepsy; CHO Cells; Cricetinae; Dopamine Antagonists; Humans; In Vitro Techniques; Male; Mice; Molecular Structure; Piperazines; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Serotonin; Structure-Activity Relationship | 1999 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28.
Topics: Amines; Humans; Imipramine; Indenes; Ligands; Molecular Structure; Receptors, Chemokine; Structure-Activity Relationship; Viral Proteins | 2010 |
Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study.
Topics: Animals; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Hydrogen Peroxide; Loxapine; Models, Molecular; Olanzapine; Oxazepines; Oxidative Stress; Piperazines; Protein Binding; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2011 |